Clinical Trials Directory

Trials / Conditions / Breakthrough Cancer Pain

Breakthrough Cancer Pain

14 registered clinical trials studyying Breakthrough Cancer Pain.

StatusTrialSponsorPhase
CompletedEffectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP
NCT05531422
Lee's Pharmaceutical LimitedPhase 2
UnknownInhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
NCT03564548
Tetra Bio-PharmaPhase 2
UnknownEffectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Canc
NCT04713189
Lee's Pharmaceutical LimitedPhase 1 / Phase 2
TerminatedTreatment of Breakthrough Cancer Pain According to European Guidelines
NCT04468490
Aziende Chimiche Riunite Angelini Francesco S.p.A—
CompletedObservational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients
NCT03895762
A.Menarini Asia-Pacific Holdings Pte Ltd—
CompletedCharacterisation and Epidemiology of Breakthrough Cancer Pain in Spain
NCT02899884
Takeda—
CompletedA Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan
NCT03669263
Chang Gung Memorial HospitalN/A
CompletedObservational Registry Study of Quality of Life When Treating BTcP With Abstral
NCT01936636
Galena Biopharma, Inc.—
CompletedProspective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments i
NCT01946555
Mario Negri Institute for Pharmacological Research—
UnknownPatient Satisfaction and Quality of Life Impact - PecFent®
NCT01693328
Archimedes Development Ltd—
UnknownPatient Satisfaction and Quality of Life Impact - PecFent®
NCT01698645
Archimedes Development Ltd—
TerminatedA Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pai
NCT01439919
SanofiPhase 2
CompletedInstanyl® Non-Interventional Study
NCT01045603
Takeda—
UnknownSafety of Fentanyl TAIFUN Treatment
NCT00822614
Akela Pharma, Inc.Phase 3